Jean Abraham

6.2k total citations
40 papers, 896 citations indexed

About

Jean Abraham is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Jean Abraham has authored 40 papers receiving a total of 896 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 20 papers in Cancer Research and 10 papers in Genetics. Recurrent topics in Jean Abraham's work include Breast Cancer Treatment Studies (15 papers), Cancer Treatment and Pharmacology (9 papers) and HER2/EGFR in Cancer Research (9 papers). Jean Abraham is often cited by papers focused on Breast Cancer Treatment Studies (15 papers), Cancer Treatment and Pharmacology (9 papers) and HER2/EGFR in Cancer Research (9 papers). Jean Abraham collaborates with scholars based in United Kingdom, Canada and Australia. Jean Abraham's co-authors include Helena Earl, Carlos Caldas, Paul D.P. Pharoah, Janet Dunn, Louise Hiller, Alison M. Dunning, Susan Ingle, Anne-Laure Vallier, Ellen Copson and Craig Luccarini and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Jean Abraham

38 papers receiving 879 citations

Peers

Jean Abraham

ONCOL

GENET

RNMI

PA Fasching Germany

Håvard Søiland Norway

Sònia Servitja Spain

Craig Luccarini United Kingdom

Angela S. Wenzlaff United States

Hege Edvardsen Norway

Mylan Pho United States

Antje Lebrecht Germany

José E. Alés‐Martínez Spain

Marike Gabrielson Sweden

PA Fasching Germany

Jean Abraham

440 ×1.1

ONCOL

328 ×1.4

229 ×1.0

GENET

102 ×0.5

108 ×1.0

RNMI

Citations per year, relative to Jean Abraham Jean Abraham (= 1×) peers PA Fasching

Countries citing papers authored by Jean Abraham

Since Specialization

Citations

This map shows the geographic impact of Jean Abraham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean Abraham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean Abraham more than expected).

Fields of papers citing papers by Jean Abraham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean Abraham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean Abraham. The network helps show where Jean Abraham may publish in the future.

Co-authorship network of co-authors of Jean Abraham

This figure shows the co-authorship network connecting the top 25 collaborators of Jean Abraham. A scholar is included among the top collaborators of Jean Abraham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean Abraham. Jean Abraham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Earl, Helena, Louise Hiller, Janet Dunn, et al.. (2025). Reduced duration adjuvant trastuzumab in the treatment of patients with HER2-positive breast cancer: a meta-analysis of randomised controlled non-inferiority trials including IPD data. PubMed. 4(1). e000810–e000810.

Abraham, Jean, Katie Snape, Katrina Tatton‐Brown, et al.. (2023). Mainstreaming of genomics in oncology: a nationwide survey of the genomics training needs of UK oncologists. Clinical Medicine. 23(1). 9–15. 11 indexed citations

Howarth, Karen, Susanna L. Cooke, Suet‐Feung Chin, et al.. (2021). NRG1 fusions in breast cancer. Breast Cancer Research. 23(1). 3–3. 17 indexed citations

Teixeira, Felipe R., Oscar M. Rueda, Jean Abraham, et al.. (2019). Fbxl17 is rearranged in breast cancer and loss of its activity leads to increased global O-GlcNAcylation. Cellular and Molecular Life Sciences. 77(13). 2605–2620. 8 indexed citations

Ali, Hager R., A. Dariush, Jeremy Thomas, et al.. (2017). Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial. Annals of Oncology. 28(8). 1832–1835. 31 indexed citations

Earl, Helena, Louise Hiller, Janet Dunn, et al.. (2017). Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer: ARTemis Trial. Annals of Oncology. 28(8). 1817–1824. 28 indexed citations

Dorling, Leila, Siddhartha Kar, Kyriaki Michailidou, et al.. (2016). The Relationship between Common Genetic Markers of Breast Cancer Risk and Chemotherapy-Induced Toxicity: A Case-Control Study. PLoS ONE. 11(7). e0158984–e0158984. 8 indexed citations

Ali, H. Raza, Aliakbar Dariush, Elena Provenzano, et al.. (2016). Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer. Breast Cancer Research. 18(1). 21–21. 64 indexed citations

Copson, Ellen, et al.. (2015). Understanding of BRCA VUS genetic results by breast cancer specialists. BMC Cancer. 15(1). 936–936. 85 indexed citations

10.

Sayal, Karen, Ioannis Gounaris, Bristi Basu, et al.. (2015). Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer. International Journal of Gynecological Cancer. 25(6). 977–984. 12 indexed citations

11.

Earl, Helena, Elena Provenzano, Jean Abraham, et al.. (2015). Neoadjuvant trials in early breast cancer: pathological response at surgery and correlation to longer term outcomes – what does it all mean?. BMC Medicine. 13(1). 234–234. 44 indexed citations

12.

Abraham, Jean, Louise Hiller, Leila Dorling, et al.. (2015). A nested cohort study of 6,248 early breast cancer patients treated in neoadjuvant and adjuvant chemotherapy trials investigating the prognostic value of chemotherapy-related toxicities. BMC Medicine. 13(1). 306–306. 25 indexed citations

13.

Wason, James, Jean Abraham, Richard D. Baird, et al.. (2015). A Bayesian adaptive design for biomarker trials with linked treatments. British Journal of Cancer. 113(5). 699–705. 22 indexed citations

14.

Abraham, Jean, Qi Guo, Leila Dorling, et al.. (2014). Replication of Genetic Polymorphisms Reported to Be Associated with Taxane-Related Sensory Neuropathy in Patients with Early Breast Cancer Treated with Paclitaxel. Clinical Cancer Research. 20(9). 2466–2475. 82 indexed citations

15.

Marmor, Schelomo, James W. Begun, Jean Abraham, & Beth A Virnig. (2014). The impact of center accreditation on hematopoietic cell transplantation (HCT). Bone Marrow Transplantation. 50(1). 87–94. 14 indexed citations

16.

Ali, Alaa M., Elena Provenzano, John M.S. Bartlett, et al.. (2013). Prognosis of early breast cancer by immunohistochemistry defined intrinsic sub-types in patients treated with adjuvant chemotherapy in the NEAT/BR9601 trial. International Journal of Cancer. 133(6). 1470–1478. 13 indexed citations

17.

Provenzano, Elena, S. Bowden, Alex Grier, et al.. (2013). A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trial. British Journal of Cancer. 108(4). 866–872. 23 indexed citations

18.

Earl, Helena, Suet‐Feung Chin, Mark Dunning, et al.. (2013). Neo-tAnGo science: A translational study of PAM 50 sub-typing in sequential fresh tissue samples during neoadjuvant chemotherapy.. Journal of Clinical Oncology. 31(15_suppl). 1015–1015. 1 indexed citations

19.

Abraham, Jean, Mel Maranian, Inmaculada Spiteri, et al.. (2012). Saliva samples are a viable alternative to blood samples as a source of DNA for high throughput genotyping. BMC Medical Genomics. 5(1). 19–19. 120 indexed citations

20.

Abraham, Jean, Patricia Harrington, Kristy Driver, et al.. (2009). Common Polymorphisms in the Prostaglandin Pathway Genes and Their Association with Breast Cancer Susceptibility and Survival. Clinical Cancer Research. 15(6). 2181–2191. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact